反応式
[CH2:1]([N:6]1[C:14]2[N:13]=[C:12]([Cl:15])[N:11]([CH2:16][CH:17]=[CH2:18])[C:10]=2[C:9](=[O:19])[NH:8][C:7]1=[O:20])[CH2:2][CH2:3][CH2:4][CH3:5].[NH:21]1[CH:25]=[C:24]([CH2:26][CH2:27][CH2:28]O)[CH:23]=[N:22]1.N(C(OCC1C=CC=CC=1)=O)=NC(OCC1C=CC=CC=1)=O.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1>C1COCC1.O>[Cl:15][C:12]1[N:11]([CH2:16][CH:17]=[CH2:18])[C:10]2[C:9](=[O:19])[N:8]([CH2:28][CH2:27][CH2:26][C:24]3[CH:25]=[N:21][NH:22][CH:23]=3)[C:7](=[O:20])[N:6]([CH2:1][CH2:2][CH2:3][CH2:4][CH3:5])[C:14]=2[N:13]=1参加物
実験手順
3-Pentyl-8-chloro-7-(2-propen-1-yl)-3,7-dihydro-1H-purine-2,6-dione (5 g, 16.86 mmol) and 3-(1H-pyrazol-4-yl)propan-1-ol (2.12 g, 16.8 mmol) were stirred in dry THF (150 ml) at 3° C. Dibenzyl azodicarboxylate (10.05 g, 33.7 mmol) was added followed by the dropwise addition of triphenylphosphine (8.83 g, 33.7 mmol) in dry THF (70 ml). The mixture was allowed to warm to it and stirred for 18 h. Water (1 ml) was added and the solvents evaporated. The residue was taken up in Et2O (200 ml) from which a white solid, mostly triphenylphosphine oxide, crystallised and was filtered off. The filtrate was concentrated and further by-products crystallised from ether-cyclohexane. The remaining filtrate was concentrated (19.2 g) and purified on a Biotage™ system (400 g) eluting with EtOAc-cyclohexane (2:1) to afford the title compound as a white solid (2.89 g).
後処理
- temperatureto warm to it
- customthe solvents evaporated
- customcrystallised
- filtrationwas filtered off
- concentrationThe filtrate was concentrated
- customfurther by-products crystallised from ether-cyclohexane
- concentrationThe remaining filtrate was concentrated (19.2 g)
- custompurified on a Biotage™ system (400 g)
- washeluting with EtOAc-cyclohexane (2:1)
出典と根拠
- ORDレコード
- ord-a351c52f866a4ef3827555a2cc86e10d
- 出典データセット
- uspto-grants-2012_03
- 特許番号
- US08143264B2
関連ノート
読み込み中…